Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00065182. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
WEEKLY IV TOPOTECAN/DOCETAXEL COMBINATION COMPARED TO DOCETAXEL IN PATIENTS WITH PRETREATED ADVANCED NSCLC: AN OPEN-LABEL MULTICENTER RANDOMIZED PHASE III TRIAL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy and safety of a weekly regimen of two FDA approved drugs in combination versus one FDA approved drug in subjects with advanced non-small cell lung cancer who have received one previous chemotherapy excluding TAXOTERE or HYCAMTIN.
Study identification
- NCT ID
- NCT00065182
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 399 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2003 (Actual)
- Primary completion
- Aug 30, 2007 (Actual)
- Completion
- Aug 30, 2007 (Actual)
- Last update posted
- Jun 24, 2019
2003 – 2007
United States locations
- U.S. sites
- 67
- U.S. states
- 30
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Huntsville | Alabama | 35801 | — |
| GSK Investigational Site | Mobile | Alabama | 36608 | — |
| GSK Investigational Site | Tucson | Arizona | 85712 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72205 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Los Angeles | California | 90067 | — |
| GSK Investigational Site | Poway | California | 92064 | — |
| GSK Investigational Site | Denver | Colorado | 80210 | — |
| GSK Investigational Site | Washington D.C. | District of Columbia | 20307-5001 | — |
| GSK Investigational Site | Washington D.C. | District of Columbia | 20422 | — |
| GSK Investigational Site | Boca Raton | Florida | 33428 | — |
| GSK Investigational Site | Boca Raton | Florida | 33486 | — |
| GSK Investigational Site | Lakeland | Florida | 33805 | — |
| GSK Investigational Site | Miami Shores | Florida | 33138 | — |
| GSK Investigational Site | Orange Park | Florida | 32073 | — |
| GSK Investigational Site | Orlando | Florida | 32804 | — |
| GSK Investigational Site | Stuart | Florida | 34994 | — |
| GSK Investigational Site | Columbus | Georgia | 31902 | — |
| GSK Investigational Site | Decatur | Illinois | 62526 | — |
| GSK Investigational Site | Elk Grove Village | Illinois | 60007 | — |
| GSK Investigational Site | Skokie | Illinois | 60077 | — |
| GSK Investigational Site | Urbana | Illinois | 61801 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46202 | — |
| GSK Investigational Site | Bowling Green | Kentucky | 42101 | — |
| GSK Investigational Site | Louisville | Kentucky | 40207 | — |
| GSK Investigational Site | Louisville | Kentucky | 40215 | — |
| GSK Investigational Site | Baton Rouge | Louisiana | 70808 | — |
| GSK Investigational Site | Lafayette | Louisiana | 70506 | — |
| GSK Investigational Site | Lake Charles | Louisiana | 70601 | — |
| GSK Investigational Site | Frederick | Maryland | 21701 | — |
| GSK Investigational Site | Boston | Massachusetts | 02118 | — |
| GSK Investigational Site | Grosse Pointe Woods | Michigan | 48236 | — |
| GSK Investigational Site | Minneapolis | Minnesota | 55407-3799 | — |
| GSK Investigational Site | Minneapolis | Minnesota | 55417 | — |
| GSK Investigational Site | Robbinsdale | Minnesota | 55422 | — |
| GSK Investigational Site | Springfield | Missouri | 65807 | — |
| GSK Investigational Site | St Louis | Missouri | 63141 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89106 | — |
| GSK Investigational Site | Reno | Nevada | 89502 | — |
| GSK Investigational Site | Hackensack | New Jersey | 07601 | — |
| GSK Investigational Site | Buffalo | New York | 14215-1199 | — |
| GSK Investigational Site | East Syracuse | New York | 13057 | — |
| GSK Investigational Site | Manhasset | New York | 11030 | — |
| GSK Investigational Site | New Hyde Park | New York | 11040 | — |
| GSK Investigational Site | Nyack | New York | 10960 | — |
| GSK Investigational Site | Rochester | New York | 14623 | — |
| GSK Investigational Site | The Bronx | New York | 10467 | — |
| GSK Investigational Site | Fayetteville | North Carolina | 28302-2000 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| GSK Investigational Site | Canton | Ohio | 44718 | — |
| GSK Investigational Site | Dunmore | Pennsylvania | 18512 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| GSK Investigational Site | Columbia | South Carolina | 29203 | — |
| GSK Investigational Site | Hilton Head Island | South Carolina | 29926 | — |
| GSK Investigational Site | Spartanburg | South Carolina | 29303 | — |
| GSK Investigational Site | Knoxville | Tennessee | 37916 | — |
| GSK Investigational Site | Nashville | Tennessee | 37203 | — |
| GSK Investigational Site | Irving | Texas | 75038 | — |
| GSK Investigational Site | Tyler | Texas | 75701 | — |
| GSK Investigational Site | Abingdon | Virginia | 24211 | — |
| GSK Investigational Site | Norfolk | Virginia | 23502 | — |
| GSK Investigational Site | Norfolk | Virginia | 23507 | — |
| GSK Investigational Site | Spokane | Washington | 99204 | — |
| GSK Investigational Site | Tacoma | Washington | 98405 | — |
| GSK Investigational Site | Milwaukee | Wisconsin | 53295 | — |
| GSK Investigational Site | Sheboygan | Wisconsin | 53081 | — |
| GSK Investigational Site | Casper | Wyoming | 85601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00065182, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2019 · Synced Oct 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00065182 live on ClinicalTrials.gov.